The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
about
Distinct Hepatic Macrophage Populations in Lean and Obese MicePediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directionsSirtuins and nonalcoholic fatty liver diseaseHepatocellular carcinoma in non-alcoholic steatohepatitis: Current knowledge and implications for management.Correlation of cell-free DNA plasma concentration with severity of non-alcoholic fatty liver disease.The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease.Non-alcoholic fatty liver disease: An expanded reviewHepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease.The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease.Different Effects of Eicosapentaenoic and Docosahexaenoic Acids on Atherogenic High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice.Administration of anti-receptor activator of nuclear factor-kappa B ligand (RANKL) antibody for the treatment of osteoporosis was associated with amelioration of hepatitis in a female patient with growth hormone deficiency: a case reportPresence of atrial fibrillation is associated with liver stiffness in an elderly Finnish population.PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic InsightsWeight loss enhances hepatic antioxidant status in a NAFLD model induced by high fat diet.The pharmacological management of NAFLD in children and adolescents.Traffic-related air pollution associations with cytokeratin-18, a marker of hepatocellular apoptosis, in an overweight and obese paediatric population.Antioxidant dietary approach in treatment of fatty liver: New insights and updates.Current and future treatment options in non-alcoholic steatohepatitis (NASH).Activin A and follistatin in patients with nonalcoholic fatty liver disease.Emerging and future therapies for nonalcoholic steatohepatitis in adults.p62/SQSTM1-Dr. Jekyll and Mr. Hyde that prevents oxidative stress but promotes liver cancer.Lipidomic Evaluation of Aryl Hydrocarbon Receptor-Mediated Hepatic Steatosis in Male and Female Mice Elicited by 2,3,7,8-Tetrachlorodibenzo-p-dioxin.A Combination of Leucine, Metformin, and Sildenafil Treats Nonalcoholic Fatty Liver Disease and Steatohepatitis in Mice.Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years.Lipid droplets and liver disease: from basic biology to clinical implications.The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.Role of folate in nonalcoholic fatty liver disease.Non-alcoholic fatty liver disease-a chronic disease of the 21(st) century.New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease (NAFLD).Nutrition, inflammation and liver-spleen axis.Inhibition of connexin hemichannels alleviates non-alcoholic steatohepatitis in mice.A Long-term Treatment with Silybin in Patients with Non-alcoholic Steatohepatitis Stimulates Catalase Activity in Human Endothelial Cells.Insulin Resistance and NAFLD: A Dangerous Liaison beyond the Genetics.Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.Cholesterol 7α-hydroxylase protects the liver from inflammation and fibrosis by maintaining cholesterol homeostasis.Effects of soy isoflavone on hepatic steatosis in high fat-induced rats.BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosisInfluence of gut microbiota on the development and progression of nonalcoholic steatohepatitis.
P2860
Q28069725-10CFC8AB-3B01-4FDE-8475-910F06D9B3CCQ28079432-2E9F3DCE-82CC-4188-B0A6-FECE3BCD0661Q28079953-0E6462B7-2758-46F3-B677-ADBFBA99805BQ30234574-062CCAD5-3109-4311-9A07-8FAFCEEC1100Q30355958-EB3CE89B-5DB9-4CE4-B147-100AE54CAB18Q33653828-85B5CE2B-1777-4472-A965-1DCB9047B142Q33789868-809A9C8D-17CD-43F9-860E-EDE37D0E0053Q33811776-1E157B90-F350-4F0F-9D4F-A12F55CBD7B9Q33831711-823DAF42-3644-4601-8ECD-A3723F71B0A2Q36059065-E20E931F-0BCE-42D6-BD42-51ECDEFBF3E3Q36203017-52BA4FBB-5670-487C-8F90-343F4051D6FAQ36306317-87612EFD-BA15-443F-B214-EA8F27E2A16AQ36939099-9E3E2016-D6C5-43F5-BF78-D5E102D38AC6Q37377220-0B5EF084-BFE3-4A85-A2A3-01A3500E7201Q37634620-00170962-B31C-4E2E-9DDE-415B871148D2Q38638081-99E076FE-693E-4094-B09E-21B9421A5B4EQ38643266-066CFDD5-74D5-4CA6-9520-2FF99D630873Q38668556-A9F4D606-6100-40AF-93BD-B4EE5D5186B3Q38685251-21CDF659-1F99-42BB-ABAE-22E26590D416Q38748381-A0F8FDBF-69DF-4AEE-8450-160B158A6F2DQ38821923-DCBCBCC4-38AC-48AA-9947-B589C2D10E46Q38827586-FCD9FB25-EA16-4E5E-9941-20A9AE208446Q38893853-42D4EC18-F9B6-486C-8378-CC106CAB3737Q38941605-D91A72B2-20B4-42F7-B088-B21039F7670FQ39044686-06A7D77C-CC72-41AA-8DB7-7A950939394FQ39104518-0328B1A7-A2CA-4B6D-A054-D92855499E82Q39253589-02B6BD49-FFA4-404F-9E50-5F1AF47B369BQ39262148-BAFE0289-6327-40BB-97DF-694B2F0E9005Q39275518-826E08B6-658B-43FC-8A0E-919C527BAA0DQ39333577-035A8916-B9A7-45B5-9585-906FF9F8F2CEQ39393326-A351EF96-3BB0-48C5-AB14-13F0F30FE168Q40086170-978BD2F5-8373-4CC1-A93C-3C5F1E64CC5EQ41419929-CAB62E9D-9B5D-4139-8150-3B9CC080E324Q41487313-BECA4646-4926-4C29-9D9A-AEE608688EE9Q41552560-611B88B9-40A5-4A85-B124-7D8A7F543F44Q41583750-02BBC86B-BA01-4A88-A221-F0D22CA9F329Q41649308-208AACBA-557A-4CBA-8750-9EC2EF591E4BQ41685550-A3E2B325-1FAF-4C06-A497-148A53FD0747Q41996948-C175D052-008D-411D-B3E7-C685C2643B71Q42000430-A3321803-DF19-403F-B44C-B988B0C6BE5F
P2860
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@ast
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@en
type
label
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@ast
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@en
prefLabel
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@ast
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@en
P1433
P1476
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD).
@en
P2093
Elena Buzzetti
Massimo Pinzani
P304
P356
10.1016/J.METABOL.2015.12.012
P577
2016-01-04T00:00:00Z